Correlation Between Ningbo MedicalSystem and Jiangsu GDK

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Ningbo MedicalSystem and Jiangsu GDK at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ningbo MedicalSystem and Jiangsu GDK into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ningbo MedicalSystem Biotechnology and Jiangsu GDK Biotechnology, you can compare the effects of market volatilities on Ningbo MedicalSystem and Jiangsu GDK and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ningbo MedicalSystem with a short position of Jiangsu GDK. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ningbo MedicalSystem and Jiangsu GDK.

Diversification Opportunities for Ningbo MedicalSystem and Jiangsu GDK

0.79
  Correlation Coefficient

Poor diversification

The 3 months correlation between Ningbo and Jiangsu is 0.79. Overlapping area represents the amount of risk that can be diversified away by holding Ningbo MedicalSystem Biotechno and Jiangsu GDK Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Jiangsu GDK Biotechnology and Ningbo MedicalSystem is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ningbo MedicalSystem Biotechnology are associated (or correlated) with Jiangsu GDK. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Jiangsu GDK Biotechnology has no effect on the direction of Ningbo MedicalSystem i.e., Ningbo MedicalSystem and Jiangsu GDK go up and down completely randomly.

Pair Corralation between Ningbo MedicalSystem and Jiangsu GDK

Assuming the 90 days trading horizon Ningbo MedicalSystem Biotechnology is expected to generate 0.69 times more return on investment than Jiangsu GDK. However, Ningbo MedicalSystem Biotechnology is 1.45 times less risky than Jiangsu GDK. It trades about -0.1 of its potential returns per unit of risk. Jiangsu GDK Biotechnology is currently generating about -0.09 per unit of risk. If you would invest  1,105  in Ningbo MedicalSystem Biotechnology on October 6, 2024 and sell it today you would lose (110.00) from holding Ningbo MedicalSystem Biotechnology or give up 9.95% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy97.73%
ValuesDaily Returns

Ningbo MedicalSystem Biotechno  vs.  Jiangsu GDK Biotechnology

 Performance 
       Timeline  
Ningbo MedicalSystem 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Ningbo MedicalSystem Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Jiangsu GDK Biotechnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Jiangsu GDK Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Ningbo MedicalSystem and Jiangsu GDK Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Ningbo MedicalSystem and Jiangsu GDK

The main advantage of trading using opposite Ningbo MedicalSystem and Jiangsu GDK positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ningbo MedicalSystem position performs unexpectedly, Jiangsu GDK can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Jiangsu GDK will offset losses from the drop in Jiangsu GDK's long position.
The idea behind Ningbo MedicalSystem Biotechnology and Jiangsu GDK Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

Other Complementary Tools

Fundamental Analysis
View fundamental data based on most recent published financial statements
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges